SCHEMBL1086378

SCHEMBL1086378

[c]1onnc1Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.42
RAB9A P51151 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
NPC1 O15118 3/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
SORT1 Q99523 1/20 0.37
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
KMT2A Q03164 1/20 0.33
CD74 P04233 1/20 0.33
MIF P14174 1/20 0.33
LMNA P02545 1/20 0.33
TAAR1 Q96RJ0 2/20 0.32
HRH3 Q9Y5N1 1/20 0.32
BCL2 P10415 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11597516 0.68 RAB9A (0.39) RAB9ASMN1; SMN2NPC1HPGDTSHR
SCHEMBL333323 0.68 CALM1 (0.42) CALM1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL29271 0.65 CALM1 (0.44) CALM1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL325246 0.64 CALM1 (0.42) CALM1RAB9ASMN1; SMN2NPC1HPGD
Diphenylmethane SCHEMBL3792579 0.64 CALM1 (1.00) CALM1HPGDTSHRALDH1A1KDM4E
Diphenylmethane SCHEMBL4361124 0.64 CALM1 (1.00) CALM1HPGDTSHRALDH1A1KDM4E
Diphenylmethane SCHEMBL28172316 0.64 CALM1 (1.00) CALM1HPGDTSHRALDH1A1KDM4E
Diphenylmethane SCHEMBL14763944 0.64 CALM1 (1.00) CALM1HPGDTSHRALDH1A1KDM4E
Diphenylmethane SCHEMBL1303 0.64 CALM1 (1.00) CALM1HPGDTSHRALDH1A1KDM4E
SCHEMBL15323022 0.63 CALM1 (0.61) CALM1RAB9ASMN1; SMN2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153795-B2 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one-compounds and the use thereof for producing drugs GRUENENTHAL GMBH (DE) 2012-04-10 US disclosed
EP-1910381-B1 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2009-06-03 EP disclosed
US-20090105290-A1 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one-Compounds and the Use Thereof for Producing Drugs GRUENENTHAL GMBH (DE) 2009-04-23 US disclosed
EP-1910381-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-04-16 EP disclosed
WO-2007000325-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105290-A1 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one-Compounds and the Use Thereof for Producing Drugs DDO, DAO, OTC CALM1 1814/4885RAB9A 4568/4885SMN1; SMN2 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.